Welcome to our dedicated page for Balchem Corporation news (Ticker: BCPC), a resource for investors and traders seeking the latest updates and insights on Balchem Corporation stock.
Founded in 1967, Balchem Corporation (NASDAQ: BCPC) offers innovative solutions and high-quality products across various industries globally. The company operates through four principal segments: Human Nutrition & Health, Specialty Products, Animal Nutrition & Health, and Industrial Products.
In the Human Nutrition & Health segment, Balchem provides essential choline nutrients and mineral amino acid chelates, supporting diverse health and nutritional applications. Their Animal Nutrition & Health segment delivers nutritional products derived from advanced microencapsulation and chelation technologies, alongside critical nutrient choline chloride, aimed at enhancing animal health.
The Specialty Products segment involves the repackaging and distribution of performance gases and chemicals, such as ethylene oxide, propylene oxide, and ammonia, for various industrial uses. Additionally, Balchem's Industrial Products segment caters to a broad range of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries.
Balchem employs approximately 1,000 people globally who are committed to driving the company into market leadership positions. Recent company achievements include their first professional sports partnership for VitaCholine®, spanning regions like the United States and the United Kingdom.
Balchem's dedication to research is evident in collaborations and studies, such as those exploring improved visuomotor performance through choline supplementation. The company's financial health and strategic growth initiatives continue to position it favorably within its chosen markets.
For more information, visit the Balchem Corporation website and stay updated with their latest news and developments.
Balchem (NASDAQ: BCPC) has declared a dividend of $0.87 per share on its common stock, payable on January 17, 2025, to stockholders of record as of December 26, 2024. This represents a 10.1% increase compared to the previous year's annual dividend. The announcement marks Balchem's sixteenth consecutive annual dividend increase, reflecting the company's consistent financial performance and the Board's confidence in their long-term strategies.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer focusing on health and nutrition markets, has announced its participation at Baird's 54th Annual Global Industrial Conference on November 13, 2024. The company will be represented by Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations) at the presentation.
Balchem (NASDAQ: BCPC) reported strong third quarter 2024 financial results with net sales of $239.9 million, up 4.3% year-over-year. The company achieved record earnings from operations and adjusted EBITDA of $64.4 million, a 7.6% increase. Net earnings rose 16.4% to $33.8 million, with earnings per share of $1.03. The Human Nutrition and Health segment showed excellent performance with 5.4% sales growth, while Specialty Products grew 10.6%. Cash flows from operations were $51.3 million, with quarterly free cash flow of $42.2 million. The company's net debt decreased to $153.3 million with a leverage ratio of 0.6 times.
Balchem (NASDAQ: BCPC) has announced a conference call scheduled for Friday, October 25, 2024, at 11:00 AM Eastern Time to review their third quarter results. The call will be hosted by Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO.
The company will release its third quarter results prior to the market opening on the same day. The press release and accompanying financial exhibits will be available on the Balchem website before the call. Interested parties can join the conference by calling toll-free 1-877-407-8289 or 1-201-689-8341 for local dial-in.
A replay of the call will be available for three hours after its conclusion until November 8, 2024. To access the replay, dial 1-877-660-6853 (local dial-in 1-201-612-7415) and use conference ID #13749359.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, has announced its participation in the HC Wainwright & Co. 26th Annual Global Investment Conference on September 9, 2024. The company will be represented by key executives including Ted Harris (Chairman of the Board, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director Investor Relations).
This presentation at a prominent investment conference provides an opportunity for Balchem to showcase its business strategies, financial performance, and growth prospects to potential investors and industry analysts. The event could potentially impact Balchem's stock performance and investor relations.
Balchem (NASDAQ: BCPC) reported strong Q2 2024 financial results with record earnings from operations and adjusted EBITDA. Key highlights include:
- Net sales of $234.1 million, up 1.2% YoY
- Adjusted EBITDA of $62.3 million, up 5.0% YoY
- GAAP net earnings of $32.1 million, up 6.5% YoY
- GAAP EPS of $0.98, compared to $0.93 in Q2 2023
- Record adjusted EPS of $1.09, up from $1.06 in Q2 2023
- Free cash flow of $38.4 million
The Human Nutrition & Health and Specialty Products segments showed strong performance with record earnings. Balchem also launched Optifolin+®, a new choline-enriched folate ingredient. The company's net debt decreased to $202.8 million, with a leverage ratio of 0.9x.
Balchem (NASDAQ: BCPC) will hold a conference call on Friday, July 26, 2024, at 11:00 AM Eastern Time (ET) to discuss second quarter financial results. The results will be published earlier that day before the market opens. Ted Harris, Chairman, President, and CEO, along with CFO Martin Bengtsson, will lead the call. The press release and financial exhibits will be available on the company's website. The call can be accessed toll-free at 1-877-407-8289, with a replay available until August 9, 2024.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer, will present at the CJS Securities 24th Annual New Ideas Summer Conference on July 10, 2024. The event is set to take place in Montvale, NJ. Ted Harris, Chairman, President, and CEO, along with CFO Martin Bengtsson and Senior Director of Investor Relations Allison Baurichter, will represent the company. This presentation highlights Balchem's commitment to engaging with investors and showcasing its market position in the health and nutrition sectors.
Balchem (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced it will present at the Wells Fargo Industrials Conference on June 12, 2024. The presentation will be made by Ted Harris, the Chairman of the Board, President, and CEO; Martin Bengtsson, the CFO; and Allison Baurichter, the Senior Director of Investor Relations. This conference attendance is expected to provide Balchem with a platform to discuss its latest strategies and developments with industry peers and investors.
Balchem (NASDAQ: BCPC) announced that they will attend the Deutsche Bank Global Consumer Conference on June 4, 2024, in Montvale, NJ. The company specializes in manufacturing specialty ingredients for health and nutrition markets.
Representing Balchem at the conference will be Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO. This event will provide an opportunity for the company to engage with investors and industry stakeholders.
FAQ
What is the current stock price of Balchem Corporation (BCPC)?
What is the market cap of Balchem Corporation (BCPC)?
What industries does Balchem Corporation serve?
What are the main segments of Balchem Corporation?
What products are offered in the Human Nutrition & Health segment?
How does the Animal Nutrition & Health segment contribute to Balchem's portfolio?
What performance gases and chemicals are included in Balchem's Specialty Products segment?
How many employees does Balchem Corporation have?
What recent achievements has Balchem Corporation made?
Where can I find more information about Balchem Corporation?
How does Balchem contribute to research?
What is Balchem's market position?
